Driver mutations in BRAF are found in approximately 50% of melanomas, play an important role in cell proliferation and metastases, and also increase inflammation by promoting secretion of pro-inflammatory cytokines, including interleukin (IL)‐6 and IL‐8 (5). Here, BRAF is linked to melanoma.